Active, Not Recruiting
Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]
NCT05536973
- Conditions
- Blindness, Choroid Diseases, Choroidal Neovascularization, +16 more
- Locations
-
- Adverum Clinical Site 178 Phoenix, Arizona, United States
- Adverum Clinical Site 126 Phoenix, Arizona, United States
- Adverum Clinical Site 159 Tucson, Arizona, United States
- Adverum Clinical Site 100 Beverly Hills, California, United States